Cargando…
Effect of cryoprecipitate transfusion without ABO group consideration: A nightmare experience
The cryoprecipitate is an essential blood product as they are rich in factor VIII, fibrinogen, von Willebrand factor, factor XIII, and fibronectin, and their volume is too small. They play a significant role in the management of massive transfusion nowadays. Usually, they are used without ABO group...
Autores principales: | Sahoo, Dibyajyoti, Silwal, Pragya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9528560/ https://www.ncbi.nlm.nih.gov/pubmed/36199410 http://dx.doi.org/10.4103/ajts.ajts_83_21 |
Ejemplares similares
-
Cryoprecipitate as an alternative to platelet transfusion in thrombocytopenia
por: Crispin, Philip, et al.
Publicado: (2021) -
Management of Bombay Rh negative with clinically significant anti-S for CABG surgery
por: Anuragaa, S., et al.
Publicado: (2022) -
ABO-incompatible granulocyte transfusion: Is ABO subgroup a barrier?
por: Agrawal, Soma, et al.
Publicado: (2022) -
Initial Results of Empirical Cryoprecipitate Transfusion in the Treatment of Isolated Severe Traumatic Brain Injury: Use of In-house-produced Cryoprecipitate
por: SHIBAHASHI, Keita, et al.
Publicado: (2019) -
Successful treatment of severe gastrointestinal manifestations of Henoch–Schonlein Purpura and factor XIII deficiency using cryoprecipitate transfusion
por: Al Sonbul, Abdullah, et al.
Publicado: (2015)